FDA Updates

In the pharmacy, an array of foot-care products awaits patients who can't stand it anymore.

New Rx, indications, generics, and OTC

Dr. Reddy’s Laboratories has launched moxifloxacin HCl tablets, 400 mg, a therapeutic equivalent generic version of Avelox on March 4, following FDA approval.

Teva Pharmaceutical Industries launched loxapine inhalation powder, 10 mg (Adasuve) March 3, for the acute treatment of agitation associated with schizophrenia or bipolar 1 disorder in adults.

FDA approved droxidopa (Northera, Chelsea Therapeutics) capsules for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating condition that is associated with Parkinson's disease, multiple-system atrophy, and pure autonomic failure.

FDA approved vortioxetine as oral tablets indicated for the treatment of major depressive disorder.

Brushes, toothpastes, rinses, whitestrips, and a gel pen -- lots of options for the dentally determined.

New Rx, generics, and OTC products for pharmacists

'Tis the season when cold-sufferers descend upon drugstores en masse.

Some helpful preparations for patients to keep handy.

New Rx, generics, OTC, and devices

Product updates for pharmacists: New Rx, generic, and OTC

A peek into a very special world.

With its interpretation, HHS effectively eliminated approximately $1.50 per reminder in payments made to pharmacies by drug manufacturers.

For women: An array of personal care products.

New Rx, indications, generics, OTC, and devices.

The 2013-2014 influenza season is the first time that quadrivalent influenza vaccines will be available in the United States. They are shipping now.

Hair treatments, shampoos and conditioners, and more.

New Rx, indications, generics, and OTC

August is a great time for many families to enjoy the outdoors before school starts. Anyone preparing for a camping trip, a hike, a boating adventure, biking, or just swimming should prepare a first aid kit for any unexpected mishaps. Some new items to add to the kit are described below.

FDA approved levomilnacipran extended-release capsules (Fetzima) for the treatment of major depressive disorder (MDD) in adults, according to the manufacturers, Forest Laboratories and Pierre Fabre Laboratories.

New Rx, indications, generics, and OTC for pharmacists

McKesson has released a mobile application it says can help improve medication adherence rates, help pharmacies operate more efficiently, and reduce hospital admissions.

FDA approved a test that identifies the genotype of hepatitis C virus (HCV) that a patient is carrying.

The U.S. Supreme Court today ruled that pay-for-delay agreements between brand name drug companies and generic manufacturers are subject to antitrust scrutiny.

Skin-care products for safe fun in the sun

New Rx, Generics, and OTC